Elliot Maza is more than just a name, he is a force driving advances in biotechnology. This dedicated life science entrepreneur has co-founded several biotechnology companies, leaving enduring marks on the industry through his innovative approach and effective leadership. 

His career spans from his early years as a registered attorney and an investment banker at prominent firms like Goldman Sachs & Co., and J.P. Morgan Securities, Inc. Here, Elliot brilliantly developed and marketed structured finance and derivative-based transactions.

Elliot's detailed knowledge and expertise have equipped him to serve on numerous Boards of Directors for OTC and NASDAQ traded biotech companies, including roles as Chairman of the Audit Committee. Until 2018, he held the position of Chief Executive Officer of the promising Immune Pharmaceuticals, Inc. He has also led the teams at Intellect Neurosciences, Inc., and Biozone Pharmaceuticals, Inc. as Chief Executive Officer and CFO, demonstrating his capabilities as a sound decision-maker.

Today, Elliot uses his extensive knowledge to provide strategic advice concerning corporate growth, investor relations, mergers and acquisitions, and license transactions, that drive the strides of a leading pharmaceutical and med-tech company. 

Both a registered attorney and a licensed C.P.A. (albeit inactive) in New York and New Jersey, Elliot bolsters an impressive resume with academic successes such as a Bachelor of Science in Accounting from Touro College and a J.D. from the lauded University of Pennsylvania Law School.

Yet, beyond Elliot's remarkable career and accomplishments, his journey is one of continued discovery, innovation, and commitment. A personal testament to the confluence of science, business, and law, he embodies what it means to be an industry front-runner. Find in Elliot Maza a compelling narrative of dedication, innovation, and pristine leadership in the ever-evolving world of biotechnology.